Detalhe da pesquisa
1.
Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101.
Proc Natl Acad Sci U S A
; 119(19): e2123483119, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507878
2.
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination.
Mol Cancer Ther
; 23(3): 285-300, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102750